nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—ESR1—liver cancer	0.82	1	CbGaD
Fluoxymesterone—Oligospermia—Epirubicin—liver cancer	0.000655	0.118	CcSEcCtD
Fluoxymesterone—Oligospermia—Doxorubicin—liver cancer	0.000606	0.109	CcSEcCtD
Fluoxymesterone—Azoospermia—Epirubicin—liver cancer	0.000509	0.092	CcSEcCtD
Fluoxymesterone—Clobetasol propionate—CYP1A1—liver cancer	0.000476	0.169	CrCbGaD
Fluoxymesterone—Azoospermia—Doxorubicin—liver cancer	0.000471	0.0852	CcSEcCtD
Fluoxymesterone—Danazol—ESR1—liver cancer	0.00047	0.167	CrCbGaD
Fluoxymesterone—Medroxyprogesterone Acetate—ESR1—liver cancer	0.000422	0.15	CrCbGaD
Fluoxymesterone—Gynaecomastia—Sorafenib—liver cancer	0.000332	0.06	CcSEcCtD
Fluoxymesterone—Progesterone—ESR1—liver cancer	0.000244	0.0865	CrCbGaD
Fluoxymesterone—Seborrhoeic dermatitis—Epirubicin—liver cancer	0.000201	0.0364	CcSEcCtD
Fluoxymesterone—Progesterone—CYP1A1—liver cancer	0.000195	0.0692	CrCbGaD
Fluoxymesterone—Haemoglobin—Sorafenib—liver cancer	0.000187	0.0339	CcSEcCtD
Fluoxymesterone—Haemorrhage—Sorafenib—liver cancer	0.000186	0.0337	CcSEcCtD
Fluoxymesterone—Norethindrone—ALB—liver cancer	0.000186	0.0661	CrCbGaD
Fluoxymesterone—Seborrhoeic dermatitis—Doxorubicin—liver cancer	0.000186	0.0336	CcSEcCtD
Fluoxymesterone—Testosterone—CYP1A1—liver cancer	0.000184	0.0654	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP2E1—liver cancer	0.000181	0.0641	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP1A1—liver cancer	0.000178	0.0633	CrCbGaD
Fluoxymesterone—Methyltestosterone—ALB—liver cancer	0.000177	0.0628	CrCbGaD
Fluoxymesterone—Alopecia—Sorafenib—liver cancer	0.000165	0.0298	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Epirubicin—liver cancer	0.000156	0.0282	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Epirubicin—liver cancer	0.000156	0.0282	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Doxorubicin—liver cancer	0.000144	0.0261	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Doxorubicin—liver cancer	0.000144	0.0261	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Sorafenib—liver cancer	0.000132	0.0239	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—PIK3CD—liver cancer	0.000124	0.000726	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CDH1—liver cancer	0.000123	0.000717	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—HNF4A—liver cancer	0.000122	0.000712	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CASP3—liver cancer	0.000122	0.000712	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CSF2—liver cancer	0.000122	0.000711	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.000121	0.000705	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—HNF4A—liver cancer	0.00012	0.000702	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—H2AFX—liver cancer	0.00012	0.000701	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000119	0.000696	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.000119	0.000694	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000119	0.000694	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CCND1—liver cancer	0.000119	0.000693	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—JUN—liver cancer	0.000118	0.000692	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CTNNB1—liver cancer	0.000118	0.000687	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IL6—liver cancer	0.000117	0.000683	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CD—liver cancer	0.000117	0.000681	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—JUN—liver cancer	0.000115	0.000674	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000114	0.000669	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CHN2—liver cancer	0.000113	0.000659	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000112	0.000657	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NR1H4—liver cancer	0.000112	0.000653	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—liver cancer	0.000111	0.000651	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—RAF1—liver cancer	0.000111	0.000649	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.00011	0.000645	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NR1I3—liver cancer	0.00011	0.000642	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—liver cancer	0.00011	0.000641	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.000109	0.000635	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TERT—liver cancer	0.000109	0.000634	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MTOR—liver cancer	0.000108	0.000633	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CB—liver cancer	0.000108	0.000633	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—EXOSC2—liver cancer	0.000108	0.000632	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—EXOSC2—liver cancer	0.000107	0.000623	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—RAF1—liver cancer	0.000104	0.000608	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—liver cancer	0.000103	0.000604	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IFT88—liver cancer	0.000103	0.000603	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000103	0.000602	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Epirubicin—liver cancer	0.000103	0.0186	CcSEcCtD
Fluoxymesterone—Testosterone—ALB—liver cancer	0.000103	0.0364	CrCbGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MTOR—liver cancer	0.000102	0.000597	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL6—liver cancer	0.000102	0.000596	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDKN1B—liver cancer	0.000102	0.000594	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MTOR—liver cancer	0.000102	0.000593	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CB—liver cancer	0.000102	0.000593	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000101	0.00059	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—HRAS—liver cancer	0.000101	0.000589	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000101	0.000589	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—AKT1—liver cancer	0.000101	0.000589	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CTNNB1—liver cancer	0.000101	0.000587	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—liver cancer	0.0001	0.000587	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL2—liver cancer	9.95e-05	0.000582	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KDR—liver cancer	9.93e-05	0.00058	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK14—liver cancer	9.86e-05	0.000576	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	9.83e-05	0.000575	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CDKN1A—liver cancer	9.82e-05	0.000574	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	9.81e-05	0.000573	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Sorafenib—liver cancer	9.76e-05	0.0176	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	9.74e-05	0.000569	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—JUN—liver cancer	9.68e-05	0.000566	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ESR1—liver cancer	9.67e-05	0.000565	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—liver cancer	9.67e-05	0.000565	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—AKT1—liver cancer	9.63e-05	0.000562	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CTNNB1—liver cancer	9.61e-05	0.000561	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—F2—liver cancer	9.56e-05	0.000558	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CDKN1B—liver cancer	9.53e-05	0.000557	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Doxorubicin—liver cancer	9.52e-05	0.0172	CcSEcCtD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MYC—liver cancer	9.52e-05	0.000556	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	9.51e-05	0.000556	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CASP3—liver cancer	9.39e-05	0.000549	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDKN1A—liver cancer	9.39e-05	0.000548	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	9.28e-05	0.000542	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK8—liver cancer	9.16e-05	0.000535	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APC—liver cancer	9.14e-05	0.000534	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CG—liver cancer	9.14e-05	0.000534	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CCND1—liver cancer	9.14e-05	0.000534	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—JUN—liver cancer	9.12e-05	0.000533	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CTNNB1—liver cancer	9.05e-05	0.000529	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CASP3—liver cancer	9.01e-05	0.000527	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—AKT1—liver cancer	8.9e-05	0.00052	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—liver cancer	8.85e-05	0.000517	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CDKN1A—liver cancer	8.8e-05	0.000514	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—KRAS—liver cancer	8.8e-05	0.000514	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—STAT3—liver cancer	8.76e-05	0.000512	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—JUN—liver cancer	8.75e-05	0.000511	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	8.69e-05	0.000508	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	8.67e-05	0.000506	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—liver cancer	8.64e-05	0.000505	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR1H4—liver cancer	8.61e-05	0.000503	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—BRAF—liver cancer	8.6e-05	0.000502	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	8.57e-05	0.000501	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NR1H4—liver cancer	8.48e-05	0.000496	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR1I3—liver cancer	8.47e-05	0.000495	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—STAT3—liver cancer	8.38e-05	0.000489	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	8.37e-05	0.000489	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NR1I3—liver cancer	8.34e-05	0.000487	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARA—liver cancer	8.31e-05	0.000486	CbGpPWpGaD
Fluoxymesterone—Headache—Sorafenib—liver cancer	8.3e-05	0.015	CcSEcCtD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	8.24e-05	0.000482	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—liver cancer	8.16e-05	0.000477	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TGFB1—liver cancer	8.12e-05	0.000474	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CD—liver cancer	8.04e-05	0.00047	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—liver cancer	7.97e-05	0.000466	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SERPINE1—liver cancer	7.95e-05	0.000465	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	7.94e-05	0.000464	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	7.89e-05	0.000461	CbGpPWpGaD
Fluoxymesterone—Nausea—Sorafenib—liver cancer	7.87e-05	0.0142	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	7.87e-05	0.00046	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—liver cancer	7.82e-05	0.000457	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	7.78e-05	0.000455	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—liver cancer	7.65e-05	0.000447	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HNF4A—liver cancer	7.62e-05	0.000445	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—liver cancer	7.58e-05	0.000443	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	7.57e-05	0.000443	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	7.56e-05	0.000442	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ESR1—liver cancer	7.53e-05	0.00044	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	7.5e-05	0.000438	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	7.35e-05	0.000429	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—liver cancer	7.33e-05	0.000428	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	7.33e-05	0.000428	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	7.29e-05	0.000426	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KRAS—liver cancer	7.19e-05	0.00042	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RAF1—liver cancer	7.18e-05	0.000419	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	7.15e-05	0.000418	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MTOR—liver cancer	7.01e-05	0.000409	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CB—liver cancer	7.01e-05	0.000409	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—liver cancer	6.97e-05	0.000407	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Epirubicin—liver cancer	6.93e-05	0.0125	CcSEcCtD
Fluoxymesterone—Haemorrhage—Epirubicin—liver cancer	6.89e-05	0.0124	CcSEcCtD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARG—liver cancer	6.87e-05	0.000402	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—liver cancer	6.78e-05	0.000396	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KRAS—liver cancer	6.74e-05	0.000394	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	6.7e-05	0.000391	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PSMA4—liver cancer	6.66e-05	0.000389	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PSMD10—liver cancer	6.66e-05	0.000389	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CA—liver cancer	6.61e-05	0.000386	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	6.6e-05	0.000386	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—liver cancer	6.6e-05	0.000386	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1B—liver cancer	6.58e-05	0.000384	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—liver cancer	6.55e-05	0.000383	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	6.48e-05	0.000378	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CASP3—liver cancer	6.44e-05	0.000377	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL2—liver cancer	6.44e-05	0.000376	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Doxorubicin—liver cancer	6.41e-05	0.0116	CcSEcCtD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARA—liver cancer	6.4e-05	0.000374	CbGpPWpGaD
Fluoxymesterone—Haemorrhage—Doxorubicin—liver cancer	6.38e-05	0.0115	CcSEcCtD
Fluoxymesterone—ESR1—Signaling Pathways—SHC3—liver cancer	6.32e-05	0.000369	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARA—liver cancer	6.31e-05	0.000369	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—liver cancer	6.27e-05	0.000367	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—JUN—liver cancer	6.26e-05	0.000366	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CTNNB1—liver cancer	6.21e-05	0.000363	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CA—liver cancer	6.19e-05	0.000362	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—SERPINE1—liver cancer	6.19e-05	0.000362	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—liver cancer	6.12e-05	0.000358	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HRAS—liver cancer	6.11e-05	0.000357	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP9—liver cancer	6.09e-05	0.000356	CbGpPWpGaD
Fluoxymesterone—Alopecia—Epirubicin—liver cancer	6.09e-05	0.011	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	6.08e-05	0.000355	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1A—liver cancer	6.07e-05	0.000355	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	6.06e-05	0.000354	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—liver cancer	6.02e-05	0.000352	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK8—liver cancer	5.92e-05	0.000346	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HNF4A—liver cancer	5.87e-05	0.000343	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—liver cancer	5.85e-05	0.000342	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HNF4A—liver cancer	5.78e-05	0.000338	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—liver cancer	5.73e-05	0.000335	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR1—liver cancer	5.71e-05	0.000334	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	5.66e-05	0.000331	CbGpPWpGaD
Fluoxymesterone—Alopecia—Doxorubicin—liver cancer	5.63e-05	0.0102	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	5.61e-05	0.000328	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—liver cancer	5.48e-05	0.00032	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	5.47e-05	0.00032	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—liver cancer	5.47e-05	0.00032	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STAT3—liver cancer	5.42e-05	0.000316	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—liver cancer	5.4e-05	0.000315	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARG—liver cancer	5.29e-05	0.000309	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—liver cancer	5.29e-05	0.000309	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARG—liver cancer	5.21e-05	0.000305	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	5.16e-05	0.000301	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PSMA4—liver cancer	5.13e-05	0.0003	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PSMD10—liver cancer	5.13e-05	0.0003	CbGpPWpGaD
Fluoxymesterone—Anxiety—Epirubicin—liver cancer	5.09e-05	0.00919	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—liver cancer	5.09e-05	0.000297	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—liver cancer	5.06e-05	0.000296	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PSMA4—liver cancer	5.05e-05	0.000295	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PSMD10—liver cancer	5.05e-05	0.000295	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—liver cancer	5.03e-05	0.000294	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFB1—liver cancer	5.02e-05	0.000293	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	4.99e-05	0.000292	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FST—liver cancer	4.91e-05	0.000287	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Epirubicin—liver cancer	4.9e-05	0.00884	CcSEcCtD
Fluoxymesterone—ESR1—Generic Transcription Pathway—SERPINE1—liver cancer	4.77e-05	0.000279	CbGpPWpGaD
Fluoxymesterone—Anxiety—Doxorubicin—liver cancer	4.71e-05	0.00851	CcSEcCtD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—SERPINE1—liver cancer	4.7e-05	0.000274	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TRIO—liver cancer	4.68e-05	0.000274	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KRAS—liver cancer	4.65e-05	0.000272	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Doxorubicin—liver cancer	4.53e-05	0.00818	CcSEcCtD
Fluoxymesterone—AR—Gene Expression—H2AFX—liver cancer	4.5e-05	0.000263	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCR4—liver cancer	4.49e-05	0.000262	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Epirubicin—liver cancer	4.4e-05	0.00794	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CA—liver cancer	4.27e-05	0.00025	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	4.21e-05	0.000246	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—liver cancer	4.13e-05	0.000241	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Doxorubicin—liver cancer	4.07e-05	0.00735	CcSEcCtD
Fluoxymesterone—AR—Gene Expression—PPARA—liver cancer	4e-05	0.000234	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—liver cancer	3.95e-05	0.000231	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—liver cancer	3.92e-05	0.000229	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—liver cancer	3.78e-05	0.000221	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MAPK14—liver cancer	3.7e-05	0.000216	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR1—liver cancer	3.63e-05	0.000212	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Epirubicin—liver cancer	3.61e-05	0.00652	CcSEcCtD
Fluoxymesterone—ESR1—Signaling Pathways—ADAM17—liver cancer	3.55e-05	0.000207	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—liver cancer	3.49e-05	0.000204	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—H2AFX—liver cancer	3.47e-05	0.000203	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—H2AFX—liver cancer	3.41e-05	0.000199	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Doxorubicin—liver cancer	3.34e-05	0.00603	CcSEcCtD
Fluoxymesterone—ESR1—Signaling Pathways—PSMA4—liver cancer	3.34e-05	0.000195	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PSMD10—liver cancer	3.34e-05	0.000195	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARG—liver cancer	3.31e-05	0.000193	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARA—liver cancer	3.08e-05	0.00018	CbGpPWpGaD
Fluoxymesterone—Headache—Epirubicin—liver cancer	3.07e-05	0.00554	CcSEcCtD
Fluoxymesterone—NR3C1—Gene Expression—PPARA—liver cancer	3.04e-05	0.000177	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—liver cancer	3.02e-05	0.000176	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SERPINE1—liver cancer	2.98e-05	0.000174	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—liver cancer	2.97e-05	0.000174	CbGpPWpGaD
Fluoxymesterone—Nausea—Epirubicin—liver cancer	2.91e-05	0.00525	CcSEcCtD
Fluoxymesterone—ESR1—Gene Expression—MAPK14—liver cancer	2.85e-05	0.000166	CbGpPWpGaD
Fluoxymesterone—Headache—Doxorubicin—liver cancer	2.84e-05	0.00513	CcSEcCtD
Fluoxymesterone—NR3C1—Gene Expression—MAPK14—liver cancer	2.8e-05	0.000164	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR1—liver cancer	2.75e-05	0.000161	CbGpPWpGaD
Fluoxymesterone—Nausea—Doxorubicin—liver cancer	2.69e-05	0.00486	CcSEcCtD
Fluoxymesterone—ESR1—Signaling Pathways—PRKCE—liver cancer	2.58e-05	0.000151	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARG—liver cancer	2.55e-05	0.000149	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARG—liver cancer	2.51e-05	0.000147	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF2—liver cancer	2.45e-05	0.000143	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SERPINE1—liver cancer	2.3e-05	0.000134	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CSF2—liver cancer	2.29e-05	0.000134	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SERPINE1—liver cancer	2.26e-05	0.000132	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—H2AFX—liver cancer	2.25e-05	0.000132	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TERT—liver cancer	2.04e-05	0.000119	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—liver cancer	1.89e-05	0.00011	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KDR—liver cancer	1.86e-05	0.000109	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK14—liver cancer	1.85e-05	0.000108	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—F2—liver cancer	1.79e-05	0.000105	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APC—liver cancer	1.72e-05	0.0001	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CG—liver cancer	1.72e-05	0.0001	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—BRAF—liver cancer	1.61e-05	9.43e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CD—liver cancer	1.51e-05	8.82e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SERPINE1—liver cancer	1.49e-05	8.72e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—liver cancer	1.45e-05	8.49e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—liver cancer	1.43e-05	8.36e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RAF1—liver cancer	1.35e-05	7.87e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CB—liver cancer	1.32e-05	7.69e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MTOR—liver cancer	1.32e-05	7.69e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—liver cancer	1.31e-05	7.64e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1B—liver cancer	1.23e-05	7.21e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASP3—liver cancer	1.21e-05	7.07e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL2—liver cancer	1.21e-05	7.06e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—liver cancer	1.18e-05	6.88e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JUN—liver cancer	1.18e-05	6.87e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CTNNB1—liver cancer	1.17e-05	6.82e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP9—liver cancer	1.14e-05	6.68e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1A—liver cancer	1.14e-05	6.66e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK8—liver cancer	1.11e-05	6.5e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—liver cancer	1.03e-05	6e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT3—liver cancer	1.02e-05	5.94e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—liver cancer	1.01e-05	5.89e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—liver cancer	9.92e-06	5.8e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—liver cancer	9.45e-06	5.52e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFB1—liver cancer	9.43e-06	5.51e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KRAS—liver cancer	8.73e-06	5.1e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CA—liver cancer	8.02e-06	4.69e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—liver cancer	7.76e-06	4.53e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—liver cancer	7.42e-06	4.34e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—liver cancer	7.1e-06	4.15e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—liver cancer	6.55e-06	3.83e-05	CbGpPWpGaD
